Sanofi Pasteur Covid vaccine approved

A Covid-19 vaccine by Sanofi Pasteur has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).

VidPrevtyn Beta is the seventh Covid-19 vaccine approved by MHRA, the independent medicines regulator.

VidPrevtyn Beta combines the spike protein from a COVID virus variant, Beta, with an ‘adjuvant’ – an additional ingredient designed to trigger a stronger immune response.

The authorisation is for the use of this vaccine in those aged 18 and over, as a heterologous booster dose, given as a single injection, so those who already received a different vaccine (mRNA or viral-vectored) can receive this vaccine as a booster.

Image by Angelo Esslinger from Pixabay

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho